ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Doxifluridine Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-17U5994
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Doxifluridine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Doxifluridine Market Research Report 2025

Code: QYRE-Auto-17U5994
Report
September 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ipsen S A
Roche
Nippon Kayaku
DSM Nutritional Products AG
Jiangsu Zhengda Qingjiang Pharmaceutical
Tonghua Maoxiang Pharmaceutical
Shandong New Era Pharmaceutical
Anhui Huarun Jinchan Pharmaceutical
Jiangsu Shengdi Pharmaceutical
Shandong Xinqi Pharmaceutical
Shaanxi Dongtai Pharmaceutical
Jilin Aodong Medicine Yanji
Zhejiang Guobang Pharmaceutical
Zhejiang Haizheng Pharmaceutical
Yangtze Pharmaceutical Group
Ningbo Tianheng Pharmaceutical
Shanghai Pacific Pharmaceutical
Shanghai Zhaohui Pharmaceutical
Zibo Wanjie Pharmaceutical
Jiangsu Hengrui Pharmaceutical
Hainan General Tongmeng Pharmaceutical

Doxifluridine Market

The global market for Doxifluridine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
It is antitumor drug, is the precursor of fluorouracil (5 FU), within the tumor tissue by the effect of pyrimidine nucleoside phosphorylase, converted to free fluorouracil, thereby inhibiting tumor cell biosynthesis of DNA, RNA, shows that its anti-tumor effect. Due to the activity of the enzyme in the tumor tissue compared with normal tissue is high, so the product in tumor converted into 5 - FU speed for selective tumor. For the treatment of breast cancer, gastric cancer, colorectal cancer,
North American market for Doxifluridine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Doxifluridine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Doxifluridine in Antimetabolic Use is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Doxifluridine include Ipsen, Roche, Nippon Kayaku, DSM Nutritional Products AG, Jiangsu Zhengda Qingjiang Pharmaceutical, Tonghua Maoxiang Pharmaceutical, Shandong New Era Pharmaceutical, Anhui Huarun Jinchan Pharmaceutical, Jiangsu Shengdi Pharmaceutical, Shandong Xinqi Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Doxifluridine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Doxifluridine.
The Doxifluridine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Doxifluridine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Doxifluridine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Doxifluridine Market Report

Report Metric Details
Report Name Doxifluridine Market
Segment by Type
  • Injection
  • Tablets
  • Capsule
Segment by Application
  • Antimetabolic Use
  • Hormone
  • Cancer Drugs
  • Antibiotic Medicine
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ipsen, Roche, Nippon Kayaku, DSM Nutritional Products AG, Jiangsu Zhengda Qingjiang Pharmaceutical, Tonghua Maoxiang Pharmaceutical, Shandong New Era Pharmaceutical, Anhui Huarun Jinchan Pharmaceutical, Jiangsu Shengdi Pharmaceutical, Shandong Xinqi Pharmaceutical, Shaanxi Dongtai Pharmaceutical, Jilin Aodong Medicine Yanji, Zhejiang Guobang Pharmaceutical, Zhejiang Haizheng Pharmaceutical, Yangtze Pharmaceutical Group, Ningbo Tianheng Pharmaceutical, Shanghai Pacific Pharmaceutical, Shanghai Zhaohui Pharmaceutical, Zibo Wanjie Pharmaceutical, Jiangsu Hengrui Pharmaceutical, Hainan General Tongmeng Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Doxifluridine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Doxifluridine Market report?

Ans: The main players in the Doxifluridine Market are Ipsen, Roche, Nippon Kayaku, DSM Nutritional Products AG, Jiangsu Zhengda Qingjiang Pharmaceutical, Tonghua Maoxiang Pharmaceutical, Shandong New Era Pharmaceutical, Anhui Huarun Jinchan Pharmaceutical, Jiangsu Shengdi Pharmaceutical, Shandong Xinqi Pharmaceutical, Shaanxi Dongtai Pharmaceutical, Jilin Aodong Medicine Yanji, Zhejiang Guobang Pharmaceutical, Zhejiang Haizheng Pharmaceutical, Yangtze Pharmaceutical Group, Ningbo Tianheng Pharmaceutical, Shanghai Pacific Pharmaceutical, Shanghai Zhaohui Pharmaceutical, Zibo Wanjie Pharmaceutical, Jiangsu Hengrui Pharmaceutical, Hainan General Tongmeng Pharmaceutical

What are the Application segmentation covered in the Doxifluridine Market report?

Ans: The Applications covered in the Doxifluridine Market report are Antimetabolic Use, Hormone, Cancer Drugs, Antibiotic Medicine

What are the Type segmentation covered in the Doxifluridine Market report?

Ans: The Types covered in the Doxifluridine Market report are Injection, Tablets, Capsule

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Doxifluridine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Injection
1.2.3 Tablets
1.2.4 Capsule
1.3 Market by Application
1.3.1 Global Doxifluridine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Antimetabolic Use
1.3.3 Hormone
1.3.4 Cancer Drugs
1.3.5 Antibiotic Medicine
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Doxifluridine Market Perspective (2020-2031)
2.2 Global Doxifluridine Growth Trends by Region
2.2.1 Global Doxifluridine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Doxifluridine Historic Market Size by Region (2020-2025)
2.2.3 Doxifluridine Forecasted Market Size by Region (2026-2031)
2.3 Doxifluridine Market Dynamics
2.3.1 Doxifluridine Industry Trends
2.3.2 Doxifluridine Market Drivers
2.3.3 Doxifluridine Market Challenges
2.3.4 Doxifluridine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Doxifluridine Players by Revenue
3.1.1 Global Top Doxifluridine Players by Revenue (2020-2025)
3.1.2 Global Doxifluridine Revenue Market Share by Players (2020-2025)
3.2 Global Doxifluridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Doxifluridine Revenue
3.4 Global Doxifluridine Market Concentration Ratio
3.4.1 Global Doxifluridine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Doxifluridine Revenue in 2024
3.5 Global Key Players of Doxifluridine Head office and Area Served
3.6 Global Key Players of Doxifluridine, Product and Application
3.7 Global Key Players of Doxifluridine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Doxifluridine Breakdown Data by Type
4.1 Global Doxifluridine Historic Market Size by Type (2020-2025)
4.2 Global Doxifluridine Forecasted Market Size by Type (2026-2031)
5 Doxifluridine Breakdown Data by Application
5.1 Global Doxifluridine Historic Market Size by Application (2020-2025)
5.2 Global Doxifluridine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Doxifluridine Market Size (2020-2031)
6.2 North America Doxifluridine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Doxifluridine Market Size by Country (2020-2025)
6.4 North America Doxifluridine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Doxifluridine Market Size (2020-2031)
7.2 Europe Doxifluridine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Doxifluridine Market Size by Country (2020-2025)
7.4 Europe Doxifluridine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Doxifluridine Market Size (2020-2031)
8.2 Asia-Pacific Doxifluridine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Doxifluridine Market Size by Region (2020-2025)
8.4 Asia-Pacific Doxifluridine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Doxifluridine Market Size (2020-2031)
9.2 Latin America Doxifluridine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Doxifluridine Market Size by Country (2020-2025)
9.4 Latin America Doxifluridine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Doxifluridine Market Size (2020-2031)
10.2 Middle East & Africa Doxifluridine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Doxifluridine Market Size by Country (2020-2025)
10.4 Middle East & Africa Doxifluridine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ipsen
11.1.1 Ipsen Company Details
11.1.2 Ipsen Business Overview
11.1.3 Ipsen Doxifluridine Introduction
11.1.4 Ipsen Revenue in Doxifluridine Business (2020-2025)
11.1.5 Ipsen Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Doxifluridine Introduction
11.2.4 Roche Revenue in Doxifluridine Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Nippon Kayaku
11.3.1 Nippon Kayaku Company Details
11.3.2 Nippon Kayaku Business Overview
11.3.3 Nippon Kayaku Doxifluridine Introduction
11.3.4 Nippon Kayaku Revenue in Doxifluridine Business (2020-2025)
11.3.5 Nippon Kayaku Recent Development
11.4 DSM Nutritional Products AG
11.4.1 DSM Nutritional Products AG Company Details
11.4.2 DSM Nutritional Products AG Business Overview
11.4.3 DSM Nutritional Products AG Doxifluridine Introduction
11.4.4 DSM Nutritional Products AG Revenue in Doxifluridine Business (2020-2025)
11.4.5 DSM Nutritional Products AG Recent Development
11.5 Jiangsu Zhengda Qingjiang Pharmaceutical
11.5.1 Jiangsu Zhengda Qingjiang Pharmaceutical Company Details
11.5.2 Jiangsu Zhengda Qingjiang Pharmaceutical Business Overview
11.5.3 Jiangsu Zhengda Qingjiang Pharmaceutical Doxifluridine Introduction
11.5.4 Jiangsu Zhengda Qingjiang Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.5.5 Jiangsu Zhengda Qingjiang Pharmaceutical Recent Development
11.6 Tonghua Maoxiang Pharmaceutical
11.6.1 Tonghua Maoxiang Pharmaceutical Company Details
11.6.2 Tonghua Maoxiang Pharmaceutical Business Overview
11.6.3 Tonghua Maoxiang Pharmaceutical Doxifluridine Introduction
11.6.4 Tonghua Maoxiang Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.6.5 Tonghua Maoxiang Pharmaceutical Recent Development
11.7 Shandong New Era Pharmaceutical
11.7.1 Shandong New Era Pharmaceutical Company Details
11.7.2 Shandong New Era Pharmaceutical Business Overview
11.7.3 Shandong New Era Pharmaceutical Doxifluridine Introduction
11.7.4 Shandong New Era Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.7.5 Shandong New Era Pharmaceutical Recent Development
11.8 Anhui Huarun Jinchan Pharmaceutical
11.8.1 Anhui Huarun Jinchan Pharmaceutical Company Details
11.8.2 Anhui Huarun Jinchan Pharmaceutical Business Overview
11.8.3 Anhui Huarun Jinchan Pharmaceutical Doxifluridine Introduction
11.8.4 Anhui Huarun Jinchan Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.8.5 Anhui Huarun Jinchan Pharmaceutical Recent Development
11.9 Jiangsu Shengdi Pharmaceutical
11.9.1 Jiangsu Shengdi Pharmaceutical Company Details
11.9.2 Jiangsu Shengdi Pharmaceutical Business Overview
11.9.3 Jiangsu Shengdi Pharmaceutical Doxifluridine Introduction
11.9.4 Jiangsu Shengdi Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.9.5 Jiangsu Shengdi Pharmaceutical Recent Development
11.10 Shandong Xinqi Pharmaceutical
11.10.1 Shandong Xinqi Pharmaceutical Company Details
11.10.2 Shandong Xinqi Pharmaceutical Business Overview
11.10.3 Shandong Xinqi Pharmaceutical Doxifluridine Introduction
11.10.4 Shandong Xinqi Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.10.5 Shandong Xinqi Pharmaceutical Recent Development
11.11 Shaanxi Dongtai Pharmaceutical
11.11.1 Shaanxi Dongtai Pharmaceutical Company Details
11.11.2 Shaanxi Dongtai Pharmaceutical Business Overview
11.11.3 Shaanxi Dongtai Pharmaceutical Doxifluridine Introduction
11.11.4 Shaanxi Dongtai Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.11.5 Shaanxi Dongtai Pharmaceutical Recent Development
11.12 Jilin Aodong Medicine Yanji
11.12.1 Jilin Aodong Medicine Yanji Company Details
11.12.2 Jilin Aodong Medicine Yanji Business Overview
11.12.3 Jilin Aodong Medicine Yanji Doxifluridine Introduction
11.12.4 Jilin Aodong Medicine Yanji Revenue in Doxifluridine Business (2020-2025)
11.12.5 Jilin Aodong Medicine Yanji Recent Development
11.13 Zhejiang Guobang Pharmaceutical
11.13.1 Zhejiang Guobang Pharmaceutical Company Details
11.13.2 Zhejiang Guobang Pharmaceutical Business Overview
11.13.3 Zhejiang Guobang Pharmaceutical Doxifluridine Introduction
11.13.4 Zhejiang Guobang Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.13.5 Zhejiang Guobang Pharmaceutical Recent Development
11.14 Zhejiang Haizheng Pharmaceutical
11.14.1 Zhejiang Haizheng Pharmaceutical Company Details
11.14.2 Zhejiang Haizheng Pharmaceutical Business Overview
11.14.3 Zhejiang Haizheng Pharmaceutical Doxifluridine Introduction
11.14.4 Zhejiang Haizheng Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.14.5 Zhejiang Haizheng Pharmaceutical Recent Development
11.15 Yangtze Pharmaceutical Group
11.15.1 Yangtze Pharmaceutical Group Company Details
11.15.2 Yangtze Pharmaceutical Group Business Overview
11.15.3 Yangtze Pharmaceutical Group Doxifluridine Introduction
11.15.4 Yangtze Pharmaceutical Group Revenue in Doxifluridine Business (2020-2025)
11.15.5 Yangtze Pharmaceutical Group Recent Development
11.16 Ningbo Tianheng Pharmaceutical
11.16.1 Ningbo Tianheng Pharmaceutical Company Details
11.16.2 Ningbo Tianheng Pharmaceutical Business Overview
11.16.3 Ningbo Tianheng Pharmaceutical Doxifluridine Introduction
11.16.4 Ningbo Tianheng Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.16.5 Ningbo Tianheng Pharmaceutical Recent Development
11.17 Shanghai Pacific Pharmaceutical
11.17.1 Shanghai Pacific Pharmaceutical Company Details
11.17.2 Shanghai Pacific Pharmaceutical Business Overview
11.17.3 Shanghai Pacific Pharmaceutical Doxifluridine Introduction
11.17.4 Shanghai Pacific Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.17.5 Shanghai Pacific Pharmaceutical Recent Development
11.18 Shanghai Zhaohui Pharmaceutical
11.18.1 Shanghai Zhaohui Pharmaceutical Company Details
11.18.2 Shanghai Zhaohui Pharmaceutical Business Overview
11.18.3 Shanghai Zhaohui Pharmaceutical Doxifluridine Introduction
11.18.4 Shanghai Zhaohui Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.18.5 Shanghai Zhaohui Pharmaceutical Recent Development
11.19 Zibo Wanjie Pharmaceutical
11.19.1 Zibo Wanjie Pharmaceutical Company Details
11.19.2 Zibo Wanjie Pharmaceutical Business Overview
11.19.3 Zibo Wanjie Pharmaceutical Doxifluridine Introduction
11.19.4 Zibo Wanjie Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.19.5 Zibo Wanjie Pharmaceutical Recent Development
11.20 Jiangsu Hengrui Pharmaceutical
11.20.1 Jiangsu Hengrui Pharmaceutical Company Details
11.20.2 Jiangsu Hengrui Pharmaceutical Business Overview
11.20.3 Jiangsu Hengrui Pharmaceutical Doxifluridine Introduction
11.20.4 Jiangsu Hengrui Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.20.5 Jiangsu Hengrui Pharmaceutical Recent Development
11.21 Hainan General Tongmeng Pharmaceutical
11.21.1 Hainan General Tongmeng Pharmaceutical Company Details
11.21.2 Hainan General Tongmeng Pharmaceutical Business Overview
11.21.3 Hainan General Tongmeng Pharmaceutical Doxifluridine Introduction
11.21.4 Hainan General Tongmeng Pharmaceutical Revenue in Doxifluridine Business (2020-2025)
11.21.5 Hainan General Tongmeng Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Ipsen S A
Roche
Nippon Kayaku
DSM Nutritional Products AG
Jiangsu Zhengda Qingjiang Pharmaceutical
Tonghua Maoxiang Pharmaceutical
Shandong New Era Pharmaceutical
Anhui Huarun Jinchan Pharmaceutical
Jiangsu Shengdi Pharmaceutical
Shandong Xinqi Pharmaceutical
Shaanxi Dongtai Pharmaceutical
Jilin Aodong Medicine Yanji
Zhejiang Guobang Pharmaceutical
Zhejiang Haizheng Pharmaceutical
Yangtze Pharmaceutical Group
Ningbo Tianheng Pharmaceutical
Shanghai Pacific Pharmaceutical
Shanghai Zhaohui Pharmaceutical
Zibo Wanjie Pharmaceutical
Jiangsu Hengrui Pharmaceutical
Hainan General Tongmeng Pharmaceutical
List of Tables
 Table 1. Global Doxifluridine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Injection
 Table 3. Key Players of Tablets
 Table 4. Key Players of Capsule
 Table 5. Global Doxifluridine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Doxifluridine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Doxifluridine Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Doxifluridine Market Share by Region (2020-2025)
 Table 9. Global Doxifluridine Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Doxifluridine Market Share by Region (2026-2031)
 Table 11. Doxifluridine Market Trends
 Table 12. Doxifluridine Market Drivers
 Table 13. Doxifluridine Market Challenges
 Table 14. Doxifluridine Market Restraints
 Table 15. Global Doxifluridine Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Doxifluridine Market Share by Players (2020-2025)
 Table 17. Global Top Doxifluridine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Doxifluridine as of 2024)
 Table 18. Ranking of Global Top Doxifluridine Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Doxifluridine Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Doxifluridine, Headquarters and Area Served
 Table 21. Global Key Players of Doxifluridine, Product and Application
 Table 22. Global Key Players of Doxifluridine, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Doxifluridine Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Doxifluridine Revenue Market Share by Type (2020-2025)
 Table 26. Global Doxifluridine Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Doxifluridine Revenue Market Share by Type (2026-2031)
 Table 28. Global Doxifluridine Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Doxifluridine Revenue Market Share by Application (2020-2025)
 Table 30. Global Doxifluridine Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Doxifluridine Revenue Market Share by Application (2026-2031)
 Table 32. North America Doxifluridine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Doxifluridine Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Doxifluridine Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Doxifluridine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Doxifluridine Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Doxifluridine Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Doxifluridine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Doxifluridine Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Doxifluridine Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Doxifluridine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Doxifluridine Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Doxifluridine Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Doxifluridine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Doxifluridine Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Doxifluridine Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Ipsen Company Details
 Table 48. Ipsen Business Overview
 Table 49. Ipsen Doxifluridine Product
 Table 50. Ipsen Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 51. Ipsen Recent Development
 Table 52. Roche Company Details
 Table 53. Roche Business Overview
 Table 54. Roche Doxifluridine Product
 Table 55. Roche Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 56. Roche Recent Development
 Table 57. Nippon Kayaku Company Details
 Table 58. Nippon Kayaku Business Overview
 Table 59. Nippon Kayaku Doxifluridine Product
 Table 60. Nippon Kayaku Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 61. Nippon Kayaku Recent Development
 Table 62. DSM Nutritional Products AG Company Details
 Table 63. DSM Nutritional Products AG Business Overview
 Table 64. DSM Nutritional Products AG Doxifluridine Product
 Table 65. DSM Nutritional Products AG Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 66. DSM Nutritional Products AG Recent Development
 Table 67. Jiangsu Zhengda Qingjiang Pharmaceutical Company Details
 Table 68. Jiangsu Zhengda Qingjiang Pharmaceutical Business Overview
 Table 69. Jiangsu Zhengda Qingjiang Pharmaceutical Doxifluridine Product
 Table 70. Jiangsu Zhengda Qingjiang Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 71. Jiangsu Zhengda Qingjiang Pharmaceutical Recent Development
 Table 72. Tonghua Maoxiang Pharmaceutical Company Details
 Table 73. Tonghua Maoxiang Pharmaceutical Business Overview
 Table 74. Tonghua Maoxiang Pharmaceutical Doxifluridine Product
 Table 75. Tonghua Maoxiang Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 76. Tonghua Maoxiang Pharmaceutical Recent Development
 Table 77. Shandong New Era Pharmaceutical Company Details
 Table 78. Shandong New Era Pharmaceutical Business Overview
 Table 79. Shandong New Era Pharmaceutical Doxifluridine Product
 Table 80. Shandong New Era Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 81. Shandong New Era Pharmaceutical Recent Development
 Table 82. Anhui Huarun Jinchan Pharmaceutical Company Details
 Table 83. Anhui Huarun Jinchan Pharmaceutical Business Overview
 Table 84. Anhui Huarun Jinchan Pharmaceutical Doxifluridine Product
 Table 85. Anhui Huarun Jinchan Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 86. Anhui Huarun Jinchan Pharmaceutical Recent Development
 Table 87. Jiangsu Shengdi Pharmaceutical Company Details
 Table 88. Jiangsu Shengdi Pharmaceutical Business Overview
 Table 89. Jiangsu Shengdi Pharmaceutical Doxifluridine Product
 Table 90. Jiangsu Shengdi Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 91. Jiangsu Shengdi Pharmaceutical Recent Development
 Table 92. Shandong Xinqi Pharmaceutical Company Details
 Table 93. Shandong Xinqi Pharmaceutical Business Overview
 Table 94. Shandong Xinqi Pharmaceutical Doxifluridine Product
 Table 95. Shandong Xinqi Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 96. Shandong Xinqi Pharmaceutical Recent Development
 Table 97. Shaanxi Dongtai Pharmaceutical Company Details
 Table 98. Shaanxi Dongtai Pharmaceutical Business Overview
 Table 99. Shaanxi Dongtai Pharmaceutical Doxifluridine Product
 Table 100. Shaanxi Dongtai Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 101. Shaanxi Dongtai Pharmaceutical Recent Development
 Table 102. Jilin Aodong Medicine Yanji Company Details
 Table 103. Jilin Aodong Medicine Yanji Business Overview
 Table 104. Jilin Aodong Medicine Yanji Doxifluridine Product
 Table 105. Jilin Aodong Medicine Yanji Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 106. Jilin Aodong Medicine Yanji Recent Development
 Table 107. Zhejiang Guobang Pharmaceutical Company Details
 Table 108. Zhejiang Guobang Pharmaceutical Business Overview
 Table 109. Zhejiang Guobang Pharmaceutical Doxifluridine Product
 Table 110. Zhejiang Guobang Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 111. Zhejiang Guobang Pharmaceutical Recent Development
 Table 112. Zhejiang Haizheng Pharmaceutical Company Details
 Table 113. Zhejiang Haizheng Pharmaceutical Business Overview
 Table 114. Zhejiang Haizheng Pharmaceutical Doxifluridine Product
 Table 115. Zhejiang Haizheng Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 116. Zhejiang Haizheng Pharmaceutical Recent Development
 Table 117. Yangtze Pharmaceutical Group Company Details
 Table 118. Yangtze Pharmaceutical Group Business Overview
 Table 119. Yangtze Pharmaceutical Group Doxifluridine Product
 Table 120. Yangtze Pharmaceutical Group Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 121. Yangtze Pharmaceutical Group Recent Development
 Table 122. Ningbo Tianheng Pharmaceutical Company Details
 Table 123. Ningbo Tianheng Pharmaceutical Business Overview
 Table 124. Ningbo Tianheng Pharmaceutical Doxifluridine Product
 Table 125. Ningbo Tianheng Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 126. Ningbo Tianheng Pharmaceutical Recent Development
 Table 127. Shanghai Pacific Pharmaceutical Company Details
 Table 128. Shanghai Pacific Pharmaceutical Business Overview
 Table 129. Shanghai Pacific Pharmaceutical Doxifluridine Product
 Table 130. Shanghai Pacific Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 131. Shanghai Pacific Pharmaceutical Recent Development
 Table 132. Shanghai Zhaohui Pharmaceutical Company Details
 Table 133. Shanghai Zhaohui Pharmaceutical Business Overview
 Table 134. Shanghai Zhaohui Pharmaceutical Doxifluridine Product
 Table 135. Shanghai Zhaohui Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 136. Shanghai Zhaohui Pharmaceutical Recent Development
 Table 137. Zibo Wanjie Pharmaceutical Company Details
 Table 138. Zibo Wanjie Pharmaceutical Business Overview
 Table 139. Zibo Wanjie Pharmaceutical Doxifluridine Product
 Table 140. Zibo Wanjie Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 141. Zibo Wanjie Pharmaceutical Recent Development
 Table 142. Jiangsu Hengrui Pharmaceutical Company Details
 Table 143. Jiangsu Hengrui Pharmaceutical Business Overview
 Table 144. Jiangsu Hengrui Pharmaceutical Doxifluridine Product
 Table 145. Jiangsu Hengrui Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 146. Jiangsu Hengrui Pharmaceutical Recent Development
 Table 147. Hainan General Tongmeng Pharmaceutical Company Details
 Table 148. Hainan General Tongmeng Pharmaceutical Business Overview
 Table 149. Hainan General Tongmeng Pharmaceutical Doxifluridine Product
 Table 150. Hainan General Tongmeng Pharmaceutical Revenue in Doxifluridine Business (2020-2025) & (US$ Million)
 Table 151. Hainan General Tongmeng Pharmaceutical Recent Development
 Table 152. Research Programs/Design for This Report
 Table 153. Key Data Information from Secondary Sources
 Table 154. Key Data Information from Primary Sources
 Table 155. Authors List of This Report


List of Figures
 Figure 1. Doxifluridine Picture
 Figure 2. Global Doxifluridine Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Doxifluridine Market Share by Type: 2024 VS 2031
 Figure 4. Injection Features
 Figure 5. Tablets Features
 Figure 6. Capsule Features
 Figure 7. Global Doxifluridine Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Doxifluridine Market Share by Application: 2024 VS 2031
 Figure 9. Antimetabolic Use Case Studies
 Figure 10. Hormone Case Studies
 Figure 11. Cancer Drugs Case Studies
 Figure 12. Antibiotic Medicine Case Studies
 Figure 13. Doxifluridine Report Years Considered
 Figure 14. Global Doxifluridine Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Doxifluridine Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Doxifluridine Market Share by Region: 2024 VS 2031
 Figure 17. Global Doxifluridine Market Share by Players in 2024
 Figure 18. Global Top Doxifluridine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Doxifluridine as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Doxifluridine Revenue in 2024
 Figure 20. North America Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Doxifluridine Market Share by Country (2020-2031)
 Figure 22. United States Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Doxifluridine Market Share by Country (2020-2031)
 Figure 26. Germany Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Doxifluridine Market Share by Region (2020-2031)
 Figure 34. China Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Doxifluridine Market Share by Country (2020-2031)
 Figure 42. Mexico Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Doxifluridine Market Share by Country (2020-2031)
 Figure 46. Turkey Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Doxifluridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Ipsen Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 50. Roche Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 51. Nippon Kayaku Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 52. DSM Nutritional Products AG Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 53. Jiangsu Zhengda Qingjiang Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 54. Tonghua Maoxiang Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 55. Shandong New Era Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 56. Anhui Huarun Jinchan Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 57. Jiangsu Shengdi Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 58. Shandong Xinqi Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 59. Shaanxi Dongtai Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 60. Jilin Aodong Medicine Yanji Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 61. Zhejiang Guobang Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 62. Zhejiang Haizheng Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 63. Yangtze Pharmaceutical Group Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 64. Ningbo Tianheng Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 65. Shanghai Pacific Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 66. Shanghai Zhaohui Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 67. Zibo Wanjie Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 68. Jiangsu Hengrui Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 69. Hainan General Tongmeng Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global 5 Fluorouracil Market Insights Forecast to 2030
Global Fluorouracil 5FU Market Insights Forecast to 2030
Global Floxuridine FUDR Market Research Report 2024
Global Fluorouracil Injection Market Research Report 2025
Fluorouracil API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Capecitabine Market Research Report 2025
Fluorouracil Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global 2 4 Difluoropyrimidine Market Research Report 2024
Global Daunorubicin Market Research Report 2024
Global Teriflunomide Market Research Report 2024
Global Thymidylate Synthase Inhibitor Market Research Report 2024
Global Urinary Tract Cancer Treatment Market Research Report 2024
Global Anticancer Drugs Market Research Report 2025
Global 2 4 Dichloro 5 Methylpyrimidine Market Research Report 2024
Global FAPI for Tumor Treatment Market Research Report 2024
Global Anti tumor Drug Market Research Report 2025
Global Targeted Antitumor Drugs Market Research Report 2025
Global Kinase Inhibitors Market Insights Forecast to 2030
Global Thymidine Market Insights Forecast to 2030
Global Pirarubicin Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions